Significant Transactions (Details Textual) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|---|
Apr. 02, 2021 |
Sep. 30, 2021 |
Sep. 30, 2021 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Business Acquisition [Line Items] | |||||
| Exchangeable shares issued | 385,947 | 385,947 | 385,947 | ||
| Preferred stock liquidation, description | The special voting preferred stock has a par value of $<span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"><span><span style="border-left: none; border-right: none;">0.0001</span></span></span> per share and a preference in liquidation of $<span style="border-left: none; border-right: none;">1.00</span>. | ||||
| Stock Consideration in Cash | $ 1,000,000.0 | ||||
| Acquisition of net income | $ (3,365,226) | $ (14,114,608) | $ (18,014,765) | ||
| Ample Organics [Member] | |||||
| Business Acquisition [Line Items] | |||||
| Common stock issued in business combination, Shares | 2,281,402 | ||||
| Value of shares issued for exchangeable shares | $ 17,452,726 | ||||
| Viridian Sciences [Member] | |||||
| Business Acquisition [Line Items] | |||||
| Exchangeable shares | 1,000,000.0 | ||||
| Value of shares issued for exchangeable shares | $ 6,000 | ||||
| Recurring revenue | $ 1,900,000 | $ 1,900,000 | $ 1,900,000 | ||
| Reduction of contingent consideration | $ 6,000,000.0 | ||||
| Acquisition of net income | $ 600,000 | ||||